ConductScience.org, home

Paper41007735

The Gut-Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy.

Scuderi SA and 7 others. Biomedicines, 2025. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. The Gut-Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy. Papers, record 41007735. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41007735

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
The Gut-Brain Axis in Brain Tumors: Insights into Tumor Development, Progression, and Therapy.
PubMed
Journal
Biomedicines
PubMed
Year
2025
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
2.02, provisional
iCite
Revised in PubMed
2025-09-30
PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Scuderi SASarah Adrianahttps://orcid.org/0000-0001-8566-9739
2Ardizzone AAlessiohttps://orcid.org/0000-0002-2293-0634
3Calcaterra EElsa
4Palermo NNicoletta
5De Luca FFabiolahttps://orcid.org/0009-0000-3431-9421
6Catalfamo AAntonio
7Esposito EEmanuelahttps://orcid.org/0000-0002-2663-6387
8Capra APAnna Paolahttps://orcid.org/0000-0002-1428-3609

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References130

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134919158Magnetic Resonance Imaging Characteristics of Molecular Subgroups in Pediatric H3 K27M Mutant Diffuse Midline Glioma.Clin Neuroradiol2022https://conductscience.org/library/papers/34919158PubMed
219269895Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial.Lancet Oncol2009https://conductscience.org/library/papers/19269895PubMed
334248690Consumption of Dietary Fiber in Relation to Psychological Disorders in Adults.Front Psychiatry2021https://conductscience.org/library/papers/34248690PubMed
438724526Glioma.Nat Rev Dis Primers2024https://conductscience.org/library/papers/38724526PubMed
535345443Gut Microbiome Alterations Affect Glioma Development and Foxp3 Expression in Tumor Microenvironment in Mice.Front Oncol2022https://conductscience.org/library/papers/35345443PubMed
636080253Lipopolysaccharide-Induced Model of Neuroinflammation: Mechanisms of Action, Research Application and Future Directions for Its Use.Molecules2022https://conductscience.org/library/papers/36080253PubMed
736612214Sodium Propionate Contributes to Tumor Cell Growth Inhibition through PPAR-γ Signaling.Cancers (Basel)2022https://conductscience.org/library/papers/36612214PubMed
838790446B355252 Suppresses LPS-Induced Neuroinflammation in the Mouse Brain.Brain Sci2024https://conductscience.org/library/papers/38790446PubMed
929471030Neuroprotective effects of fecal microbiota transplantation on MPTP-induced Parkinson's disease mice: Gut microbiota, glial reaction and TLR4/TNF-α signaling pathway.Brain Behav Immun2018https://conductscience.org/library/papers/29471030PubMed
1031006109Increasing carbohydrate availability in the hindgut promotes hypothalamic neurotransmitter synthesis: aromatic amino acids linking the microbiota-brain axis.J Neurochem2019https://conductscience.org/library/papers/31006109PubMed
1130337151Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.Alzheimers Dement2019https://conductscience.org/library/papers/30337151PubMed
1233061482The Impact of Gut Microbiota Disorders on the Blood-Brain Barrier.Infect Drug Resist2020https://conductscience.org/library/papers/33061482PubMed
1338249807Gut microbiota influences the efficiency of immune checkpoint inhibitors by modulating the immune system (Review).Oncol Lett2024https://conductscience.org/library/papers/38249807PubMed
1440338411Intracellular bacterial LPS drives pyroptosis and promotes aggressive phenotype in oral squamous cell carcinoma.Med Oncol2025https://conductscience.org/library/papers/40338411PubMed
1533352931Role of Fibroblast Growth Factors Receptors (FGFRs) in Brain Tumors, Focus on Astrocytoma and Glioblastoma.Cancers (Basel)2020https://conductscience.org/library/papers/33352931PubMed
1630229438Sodium Butyrate Exerts Neuroprotective Effects in Spinal Cord Injury.Mol Neurobiol2019https://conductscience.org/library/papers/30229438PubMed
1733662679The role of gut microbiota in tumorigenesis and treatment.Biomed Pharmacother2021https://conductscience.org/library/papers/33662679PubMed
1828641579LPS alters the immuno-phenotype of glioma and glioma stem-like cells and induces in vivo antitumor immunity via TLR4.J Exp Clin Cancer Res2017https://conductscience.org/library/papers/28641579PubMed
1936709599Butyrate ameliorates chronic alcoholic central nervous damage by suppressing microglia-mediated neuroinflammation and modulating the microbiome-gut-brain axis.Biomed Pharmacother2023https://conductscience.org/library/papers/36709599PubMed
2038327950Accuracy of MRI in Detecting 1p/19q Co-deletion Status of Gliomas: A Single-Center Retrospective Study.Cureus2024https://conductscience.org/library/papers/38327950PubMed

See all 130 referencesDownload CSV of references

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
42984982Microbiome-mitochondria crosstalk in neuro-oncology: molecular mechanisms, immunometabolic reprogramming, and therapeutic opportunities.Front Microbiomes2026https://conductscience.org/library/papers/42984982PubMed
42740387Integrated Multi-Omics and Radiogenomic Analysis Identifies S100B and ITGB5 as Complementary Candidate Biomarkers of Glioblastoma Heterogeneity.Chem Biol Drug Des2026https://conductscience.org/library/papers/42740387PubMed
42238602Molecular mechanisms and clinical significance of the glioma metabolic-immune axis: a comprehensive review.Front Immunol2026https://conductscience.org/library/papers/42238602PubMed
41727337From the gut to the brain: The involvement of the gut microbiota in the development and progression of glioblastoma.Neurooncol Adv2026https://conductscience.org/library/papers/41727337PubMed
41659429Longitudinal Changes in Nasal and Oral Microbiome and Antimicrobial Resistance Gene Profiles in Response to Human Fecal Microbiota Transplantation.bioRxiv2026https://conductscience.org/library/papers/41659429PubMed
41622932[Research Progress on the Mechanism of Gut Microbiota Influencing Lung Cancer Brain Metastasis via the Brain-gut Axis].Zhongguo Fei Ai Za Zhi2025https://conductscience.org/library/papers/41622932PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41007735

GET https://conductscience.org/api/papers/v1/41007735/references?page=2